AI-based pathology predicts origins for cancers of unknown primary
Cancer of unknown primary (CUP) origin is an enigmatic group of diagnoses in which the
primary anatomical site of tumour origin cannot be determined,. This poses a considerable …
primary anatomical site of tumour origin cannot be determined,. This poses a considerable …
Progress in refining the clinical management of cancer of unknown primary in the molecular era
E Rassy, N Pavlidis - Nature reviews Clinical oncology, 2020 - nature.com
Cancer of unknown primary (CUP) is an enigmatic disease entity encompassing
heterogeneous malignancies without a detectable primary tumour, despite a thorough …
heterogeneous malignancies without a detectable primary tumour, despite a thorough …
Exploring the biological hallmarks of cancer of unknown primary: where do we stand today?
E Rassy, T Assi, N Pavlidis - British journal of cancer, 2020 - nature.com
Cancer of unknown primary (CUP) affects a small percentage of the general population.
Nonetheless, a substantial number of these patients have a poor prognosis and …
Nonetheless, a substantial number of these patients have a poor prognosis and …
Molecularly guided therapy versus chemotherapy after disease control in unfavourable cancer of unknown primary (CUPISCO): an open-label, randomised, phase 2 …
A Krämer, T Bochtler, C Pauli, KK Shiu, N Cook… - The Lancet, 2024 - thelancet.com
Background Patients with unfavourable subset cancer of unknown primary (CUP) have a
poor prognosis when treated with standard platinum-based chemotherapy. Whether first-line …
poor prognosis when treated with standard platinum-based chemotherapy. Whether first-line …
Prediction of tumor origin in cancers of unknown primary origin with cytology-based deep learning
F Tian, D Liu, N Wei, Q Fu, L Sun, W Liu, X Sui… - Nature Medicine, 2024 - nature.com
Cancer of unknown primary (CUP) site poses diagnostic challenges due to its elusive
nature. Many cases of CUP manifest as pleural and peritoneal serous effusions. Leveraging …
nature. Many cases of CUP manifest as pleural and peritoneal serous effusions. Leveraging …
New rising entities in cancer of unknown primary: Is there a real therapeutic benefit?
Abstract Cancers of Unknown Primary Site (CUP) account for approximately 1–3% of all
malignant neoplasms. It represents a heterogeneous group of malignancies without a …
malignant neoplasms. It represents a heterogeneous group of malignancies without a …
A comparison of DNA sequencing and gene expression profiling to assist tissue of origin diagnosis in cancer of unknown primary
A Posner, OW Prall, T Sivakumaran… - The Journal of …, 2023 - Wiley Online Library
Cancer of unknown primary (CUP) is a syndrome defined by clinical absence of a primary
cancer after standardised investigations. Gene expression profiling (GEP) and DNA …
cancer after standardised investigations. Gene expression profiling (GEP) and DNA …
Cancer of unknown primary: challenges and progress in clinical management
Simple Summary Patients with cancer of unknown primary site suffer the burden of an
uncertain disease, which is characterized by the impossibility to identify the tissue where the …
uncertain disease, which is characterized by the impossibility to identify the tissue where the …
International consensus on the initial diagnostic workup of cancer of unknown primary
I van der Strate, F Kazemzadeh, ID Nagtegaal… - Critical Reviews in …, 2023 - Elsevier
Background Although the incidence of Cancer of Unknown Primary (CUP) is estimated to be
1–2% of all cancers worldwide, no international standards for diagnostic workup are yet …
1–2% of all cancers worldwide, no international standards for diagnostic workup are yet …
[HTML][HTML] Site-specific therapy in cancers of unknown primary site: a systematic review and meta-analysis
Y Ding, J Jiang, J Xu, Y Chen, Y Zheng, W Jiang… - ESMO open, 2022 - Elsevier
Background Cancer of unknown primary site (CUP) is a term applied to characterize
pathologically confirmed metastatic cancer with unknown primary tumor origin. It remains …
pathologically confirmed metastatic cancer with unknown primary tumor origin. It remains …